Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. (pnas.org)

Authors: Asiedu EB … Montaner S Journal: PNAS Published: 2026-03-31 DOI: https://doi.org/10.1073/pnas.2510265123